08048035996
Global Pharma Supply of RIDSUNATE 50 MG | South Korea Export | Phoenix Exim – Trusted Supplier


1. General Information

Ridsunate 50 mg is an antimalarial tablet containing artesunate as its active ingredient. Artesunate is a fast-acting artemisinin derivative that helps reduce malaria parasite levels in the bloodstream.

Malaria treatment depends on the parasite species, geographic location where the infection was acquired, severity of illness, age, pregnancy status and other clinical factors. Current WHO guidance recommends artemisinin-based combination therapies (ACTs) for uncomplicated malaria rather than oral artesunate alone.

Ridsunate 50 mg should therefore be used as part of an appropriate malaria treatment regimen when prescribed by a healthcare professional.

2. Product Information

  • Brand Name: Ridsunate 50 mg

  • Active Ingredient: Artesunate

  • Strength: 50 mg

  • Dosage Form: Tablet

  • Therapeutic Category: Antimalarial

  • Primary Use: Treatment of malaria

  • Common Pack Size: 1 × 4 tablets, depending on the manufacturer/market

  • Manufacturer: Product listings identify Ridley as the manufacturer for Ridsunate 50 mg

  • Country of Origin: India

The exact packaging, manufacturer details and registration status can vary by market and batch, so the product pack and applicable local regulatory requirements should always be verified before supply.

3. Uses of Ridsunate 50 MG

Ridsunate 50 mg is used as part of antimalarial treatment for malaria infections caused by Plasmodium parasites.

Artesunate is particularly valuable because it acts rapidly against blood-stage malaria parasites. For uncomplicated P. falciparum malaria, WHO recommends approved ACT regimens such as artesunate-amodiaquine, artesunate-mefloquine, artesunate-pyronaridine and other appropriate ACTs rather than oral artesunate monotherapy.

It should not be used for malaria prevention and should not be relied upon as oral monotherapy for uncomplicated malaria.

4. Benefits of Ridsunate 50 MG

The potential benefits of artesunate-based malaria treatment include:

  • Helps rapidly reduce malaria parasite levels in the blood.

  • Helps control malaria infection when used in an appropriate treatment regimen.

  • Provides a fast-acting artemisinin derivative for malaria management.

  • Can contribute to rapid clearance of malaria parasites when used appropriately.

  • May help reduce malaria-related symptoms as the parasite burden decreases.

The choice of treatment should be based on malaria species, local resistance patterns and clinical severity.

5. Side Effects of Ridsunate 50 MG

Some people may experience side effects while taking artesunate-containing medicines. Possible adverse effects include:

  • Headache

  • Dizziness

  • Nausea

  • Vomiting

  • Abdominal discomfort

  • Weakness or fatigue

  • Reduced appetite

Rare but clinically important blood-related complications, including hemolytic anemia, can occur after artesunate treatment. Delayed hemolysis is particularly recognized after treatment with intravenous artesunate for severe malaria, so appropriate medical follow-up may be required.

Seek medical attention if severe weakness, unusual paleness, yellowing of the skin or eyes, dark urine, breathing difficulty or other concerning symptoms develop.

6. Common Side Effects

Commonly reported or possible side effects may include:

  1. Headache

  2. Nausea

  3. Dizziness

  4. Weakness

  5. Loss of appetite

  6. Vomiting

  7. Stomach discomfort

Most mild effects may improve during treatment, but persistent or severe symptoms should be discussed with a healthcare professional.

7. How to Use Ridsunate 50 MG

Take Ridsunate 50 mg only according to the prescribed antimalarial regimen.

  • Take the tablet exactly as directed by your healthcare professional.

  • Do not change the dose or treatment duration on your own.

  • Complete the prescribed treatment course.

  • Do not take extra tablets to compensate for a missed dose unless specifically instructed.

  • Follow the administration instructions supplied with the prescribed ACT regimen.

Importantly, oral artesunate should not be used alone for uncomplicated malaria because oral artemisinin monotherapy can contribute to the development and spread of artemisinin resistance. WHO recommends combination therapy with an appropriate partner medicine.

8. How Ridsunate 50 MG Works

Ridsunate contains artesunate, which is converted in the body to its active metabolite dihydroartemisinin (DHA).

Artesunate-based medicines act rapidly against malaria parasites, particularly during their blood stages. The artemisinin compound produces reactive substances that damage essential parasite proteins and cellular structures, leading to parasite death.

This rapid reduction in parasite numbers helps control the infection and associated malaria symptoms.

9. Safety Advice for Ridsunate 50 MG

Medical diagnosis: Malaria should ideally be confirmed using appropriate diagnostic testing before treatment. WHO recommends parasitological confirmation with microscopy or a rapid diagnostic test when available.

Do not self-medicate: Malaria can become life-threatening and requires appropriate diagnosis and treatment.

Avoid oral monotherapy: Oral artesunate alone is not recommended for uncomplicated malaria. It should be used within an appropriate combination regimen.

Severe malaria: Ridsunate 50 mg tablets should not be considered a substitute for hospital treatment of severe malaria. CDC guidance recommends prompt IV artesunate for severe malaria, followed by a complete oral antimalarial course once clinically appropriate.

Pregnancy and breastfeeding: Inform your doctor if you are pregnant, planning pregnancy or breastfeeding before starting malaria treatment.

Other medicines: Tell your healthcare professional about all prescription medicines, non-prescription medicines and supplements you are taking.

Allergy: Do not use artesunate if you have previously experienced a serious allergic reaction to artesunate or another artemisinin medicine.

Storage: Store the product according to the manufacturer's instructions, away from excessive heat, moisture and direct sunlight, and keep it out of reach of children.

10. FAQ's

Q1. What is Ridsunate 50 mg?

Ridsunate 50 mg is an antimalarial tablet containing Artesunate 50 mg, used as part of appropriate malaria treatment.

Q2. What is Ridsunate 50 mg used for?

It is used in the treatment of malaria caused by Plasmodium parasites.

Q3. Is Ridsunate 50 mg used for malaria prevention?

No. Artesunate tablets are used for treatment and should not be used as a malaria-prevention medicine.

Q4. Can Ridsunate 50 mg be taken alone?

Oral artesunate should generally not be used alone for uncomplicated malaria. WHO recommends an appropriate artemisinin-based combination therapy to improve treatment effectiveness and limit resistance.

Q5. Is Ridsunate 50 mg suitable for severe malaria?

Severe malaria requires urgent medical care. Current CDC guidance recommends IV artesunate for severe malaria rather than relying on Ridsunate 50 mg tablets.

Q6. What are the common side effects?

Possible side effects include headache, nausea, dizziness, weakness, vomiting and reduced appetite.

Q7. Can I stop the medicine when I feel better?

No. Complete the prescribed antimalarial treatment regimen unless your healthcare professional tells you otherwise.

Q8. Can Ridsunate 50 mg be used during pregnancy?

Malaria itself can be dangerous during pregnancy. The appropriate treatment should be selected by a healthcare professional based on the patient's condition and current treatment guidelines.

Q9. Can Ridsunate 50 mg treat every type of malaria?

Treatment depends on the malaria species, geographic origin of infection and severity. Additional treatment may be required for P. vivax or P. ovale to prevent relapse.

Q10. How should Ridsunate 50 mg be stored?

Store it according to the manufacturer's packaging instructions and protect it from excessive heat, moisture and direct sunlight.

11. Substitute for Ridsunate 50 MG

Possible alternatives depend on the malaria species, treatment guidelines, resistance pattern, patient age, pregnancy status and severity of infection. Therefore, a substitute should not be selected solely on the basis of the same strength.

For uncomplicated malaria, WHO-recommended ACT options may include:

  • Artemether + Lumefantrine

  • Artesunate + Amodiaquine

  • Artesunate + Mefloquine

  • Dihydroartemisinin + Piperaquine

  • Artesunate + Sulfadoxine-Pyrimethamine

  • Artesunate + Pyronaridine

The appropriate alternative must be selected by a qualified healthcare professional.

12. SEO Keywords

Ridsunate 50 mg, Ridsunate 50 mg tablets, Ridsunate Artesunate 50 mg, Artesunate 50 mg tablets, Artesunate tablets supplier, Artesunate medicine exporter India, Ridsunate 50 mg exporter, Ridsunate tablets supplier India, antimalarial tablets exporter, malaria medicine supplier India, malaria treatment tablets, Artesunate pharmaceutical supplier, Indian pharmaceutical exporter, pharma exporter from Nagpur, medicine exporter from India, Ridsunate 50 mg wholesale supplier, Artesunate 50 mg wholesale, Ridsunate medicine export, antimalarial medicine exporter, malaria tablets supplier, Ridsunate 50 mg USA supply, Ridsunate 50 mg UK supply, Artesunate Australia supplier, malaria medicine Canada supplier, Ridsunate South Korea supplier, Artesunate Singapore supplier, Ridsunate UAE supplier, Indian pharma supplier worldwide, global pharmaceutical exporter, Phoenix Exim medicine exporter, Phoenix Exim pharmaceutical supplier, genuine Artesunate tablets supplier, quality antimalarial medicine exporter, pharmaceutical export from India


Sep 11th, 2026 12:51 PM

Keywords